STOCK TITAN

Thermo Fisher (TMO) CAO Holmes exercises options and sells 420 shares at $584.81

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

THERMO FISHER SCIENTIFIC INC. executive Joseph R. Holmes, VP & Chief Accounting Officer, exercised stock options for 420 shares of common stock at an exercise price of $309.63 per share on August 7, 2026, and sold 420 shares at $584.81 per share the same day. Following the option exercise, he reported 140 stock options remaining from this grant, which expires on February 25, 2027.

Positive

  • None.

Negative

  • None.
Insider Holmes Joseph R.
Role VP & Chief Accounting Officer
Sold 420 shs ($246K)
Approx. gross sale proceeds $246K
Approx. exercise cost $130K
Approx. pre-tax spread $116K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1 420 $0.00 $0.00
Exercise Common Stock 420 $309.63 $130K
Sale Common Stock 420 $584.81 $246K
Holdings After Transaction: Stock Option (Right to Buy) — 140 shares (Direct); Common Stock — 2,966.3555 shares (Direct)
Footnotes (1)
  1. F1. The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024.
Options Exercised 420 shares Stock options exercised into common stock on August 7, 2026
Exercise Price $309.63 per share Exercise price of stock options converted into common stock
Shares Sold 420 shares Common stock sold on August 7, 2026
Sale Price $584.81 per share Per-share price for sale of 420 common shares
Options Remaining 140 shares Stock options remaining after exercise, as reported following transaction
Option Expiration February 25, 2027 Expiration date of the reported stock option grant
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: 309.6300"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2027-02-25"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Thermo Fisher (TMO) executive Joseph R. Holmes report in this Form 4?

Joseph R. Holmes reported exercising 420 stock options for Thermo Fisher common stock at $309.63 per share and selling 420 shares at $584.81 per share on August 7, 2026.

How many Thermo Fisher (TMO) shares did Joseph R. Holmes sell and at what price?

He sold 420 shares of Thermo Fisher common stock at a price of $584.81 per share on August 7, 2026, in a transaction reported as a sale.

What was the exercise price of Joseph R. Holmes’s Thermo Fisher (TMO) stock options?

The exercised stock options had an exercise price of $309.63 per share. On August 7, 2026, he exercised 420 options at this price, converting them into an equivalent number of Thermo Fisher common shares.

How many Thermo Fisher (TMO) stock options from this grant does Joseph R. Holmes retain?

After the reported transactions, he held 140 stock options from this specific grant. These remaining options are reported with an expiration date of February 25, 2027.

When do Joseph R. Holmes’s remaining Thermo Fisher (TMO) options from this grant expire?

The remaining 140 stock options from this grant are shown with an expiration date of February 25, 2027. A footnote states the option vested in four equal installments from 2021 through 2024.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Holmes Joseph R.

(Last)(First)(Middle)
168 THIRD AVENUE

(Street)
WALTHAM MASSACHUSETTS 02451

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP & Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/07/2026M420A$309.633,386.3555D
Common Stock08/07/2026S420D$584.812,966.3555D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$309.6308/07/2026M420(1) (1)02/25/2027Common Stock420$0140D
Explanation of Responses:
1. The option vested in four equal installments on February 25, 2021, 2022, 2023 and 2024.
Remarks:
/s/ Melodie T. Morin, Attorney-in-Fact for Joseph R. Holmes08/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)